Phase II Study of Biweekly Administration of Docetaxel and Irinotecan in Patients With Refractory or Relapsed Advanced Non-Small Cell Lung Cancer: P-1–149


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles